0000899243-15-003426.txt : 20150818
0000899243-15-003426.hdr.sgml : 20150818
20150818163457
ACCESSION NUMBER: 0000899243-15-003426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150814
FILED AS OF DATE: 20150818
DATE AS OF CHANGE: 20150818
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acadia Healthcare Company, Inc.
CENTRAL INDEX KEY: 0001520697
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6100 TOWER CIRCLE
STREET 2: SUITE 1000
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-861-6000
MAIL ADDRESS:
STREET 1: 6100 TOWER CIRCLE
STREET 2: SUITE 1000
CITY: FRANKLIN
STATE: TN
ZIP: 37067
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gordon Christopher R
CENTRAL INDEX KEY: 0001432313
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35331
FILM NUMBER: 151061728
MAIL ADDRESS:
STREET 1: C/O BAIN CAPITAL, LLC
STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-14
0
0001520697
Acadia Healthcare Company, Inc.
ACHC
0001432313
Gordon Christopher R
JOHN HANCOCK TOWER
200 CLARENDON ST.
BOSTON
MA
02116
1
0
0
0
Common Stock, par value $0.01
2015-08-14
4
S
0
2351137
80.47
D
3452202
I
See Footnotes
Common Stock, par value $0.01
1611
D
Bain Capital Investors, LLC ("BCI") is the general partner of Bain Capital Partners VIII, L.P. ("BCP VIII"), which is the general partner of Bain Capital Fund VIII, L.P. which is the sole member of Bain Capital Fund VIII, LLC ("Fund VIII"). On August 14, 2015, Fund VIII sold 2,000,505 shares of Common Stock. Following such sale, Fund VIII held 2,941,666 shares of Common Stock.
BCI is the general partner of BCP VIII, which is the general partner of Bain Capital VIII Coinvestment Fund, L.P., which is the sole member of Bain Capital VIII Coinvestment Fund, LLC ("Fund VIII-CO"). On August 14, 2015, Fund VIII-CO sold 268,471 shares of Common Stock. Following such sale, Fund VIII-CO held 387,155 shares of Common Stock.
BCI is also the general partner of Bain Capital (CR), L.P. ("BC CR"). On August 14, 2015, BC CR sold 10,935 shares of Common Stock. Following such sale, BC CR held 15,768 shares of Common Stock.
BCI is also the managing partner of BCIP Associates III, which is the manager of BCIP Associates III, LLC ("BCIP III"). On August 14, 2015, BCIP III sold 42,254 shares of Common Stock. Following such sale, BCIP III held 65,813 shares of Common Stock.
BCI is also the managing partner of BCIP Associates III-B, which is the manager of BCIP Associates III-B, LLC ("BCIP III-B"). On August 14, 2015, BCIP III-B sold 6,234 shares of Common Stock. Following such sale, BCIP III-B held 9,010 shares of Common Stock.
BCI is also the managing partner of BCIP Trust Associates III, which is the manager of BCIP T Associates III, LLC ("BCIPT III"). On August 14, 2015, BCIPT III sold 20,712 shares of Common Stock. Following such sale, BCIPT III held 29,868 shares of Common Stock.
BCI is also the managing partner of BCIP Trust Associates III-B, which is the manager of BCIP T Associates III-B, LLC ("BCIPT III-B"). On August 14, 2015, BCIPT III-B sold 1,273 shares of Common Stock. Following such sale, BCIPT III-B held 1,835 shares of Common Stock.
BCI is also the managing partner of BCIP Associates-G ("BCIP-G" and together with "Fund VIII, Fund VIII-CO, BC CR, BCIP III, BCIP III-B, BCIPT III and BCIP T III-B, the "Bain Entities"). On August 14, 2015, BCIP-G sold 753 shares of Common Stock. Following such sale, BCIP-G held 1,087 shares of Common Stock.
Mr. Christopher Gordon is a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Gordon may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Entities. Mr. Gordon disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Mr. Gordon was awarded a grant of 1,611 shares of Common Stock of the Issuer. These shares vest in three equal installments beginning February 26, 2016.
/s/ Christopher Gordon
2015-08-18